Dr Eddie Wang
Projects as PI
- Cellular and viral immunology resource (23/04/2006 - 22/01/2010)
- Characterisation of a novel class of natural killer cell immunoevasin (01/05/2021 - 28/02/2025)
- Commercial supply of DR3 Knock out (01/04/2015 - 29/02/2016)
- DR3 knockout (01/08/2012 - 31/07/2013)
- Exploring innate-like and adaptive gamma delta T cell paradigms in health and disease (01/03/2021 - 28/02/2026)
Projects as Co-Investigator
- An analysis of wild type human cytomegalovirus (01/12/2010 - 08/05/2014)
- A systematic investigation into human cytomegalovirus gene function (08/05/2014 - 31/12/2017)
- Automated 384-capacity real-time quantitative polymerase chain reaction (qPCR) facility (01/08/2012 - 31/07/2013)
- Death receptor 3: A regulator of bone turnover and new target for therapy for osteoporosis? (01/10/2009 - 01/10/2012)
- Developing a novel anti-SARS-CoV-2 Immunotherapy (01/01/2024 - 31/08/2025)